Altimmune to Report First Quarter 2023 Monetary Outcomes and Present Enterprise Replace on Might 11, 2023

Angelena Iglesia

Altimmune, Inc GAITHERSBURG, Md., Might 04, 2023 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical firm, right now introduced that it’ll report its first quarter 2023 monetary outcomes on Thursday, Might 11, 2023 and can present a enterprise replace. Altimmune administration will host a convention name at 8:30 […]

Subscribe US Now